NCT06929052View on ClinicalTrials.gov

A Open Label ,Randomized, Balanced, Two-treatment, Single Period, Parallel, Comparative Pharmacokinetic Study in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 29, 2025

Primary Completion Date

June 15, 2025

Study Completion Date

July 15, 2025

Conditions
Chronic Idiopathic Urticaria
Interventions
DEVICE

ADL-018 Autoinjector

Test product (A): ADL-018 Injection 150 mg/mL solution in a single dose pre-filled autoinjector manufactured/supplied by Kashiv BioSciences LLC, USA.

DRUG

ADL-018 Injection

Reference Product (B): ADL-018 Injection 150mg/mL solution in a single dose pre-filled syringe manufactured/supplied by Kashiv BioSciences LLC, USA

Trial Locations (1)

Unknown

RECRUITING

Not Disclosed, Missisauga

Sponsors
All Listed Sponsors
lead

Kashiv BioSciences, LLC

INDUSTRY

NCT06929052 - A Open Label ,Randomized, Balanced, Two-treatment, Single Period, Parallel, Comparative Pharmacokinetic Study in Healthy Subjects | Biotech Hunter | Biotech Hunter